|
Summary: MultiCell Technologies, Inc., is a leading provider of liver cell-based products for drug discovery and therapeutic applications. The Company specializes in innovative cell immortalization technologies that lead to the reproducible creation of highly functional cell lines. Visit MultiCell Technologies, Inc..
Description (Web site quote):
MultiCell has leveraged its proprietary cell technologies to engineer liver cell lines that retain their native functionality, continuously regenerate, and are non-tumorigenic.
MultiCell's majority-owned subsidiary, Xenogenics Corporation , is developing the SybiolŪ synthetic bio-liver device that optimally utilizes MultiCell's proprietary, immortalized human hepatocytes. Visit MultiCell Technologies, Inc..
|